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Abstract 
Biologically treated wastewater containing a mixture of 53 active pharmaceutical ingredients (APIs) 
was treated with 0-20 mg/l chlorine dioxide (ClO2) solution. Wastewater effluents were taken from 
two wastewater treatment plants in Sweden, one with (low COD) and one without (high COD) 
extended nitrogen removal. The removal of the APIs varied from no significant removal at the 
highest dose of ClO2 (20 mg/l) to 90% removal at a dose of 0.5 mg/l of the oxidant. From the low 
COD effluent, only 4 APIs were removed by more than 90% at the lowest oxidant dose of 0.5 mg/l 
whereas most of the APIs were removed at 5 mg/l ClO2 dose. Removal of the same APIs from the 
high COD effluent was observed when the ClO2 dose was increased to 1.25 mg/l and an increase 
in API removal only after treatment with 8 mg/l ClO2. This illustrates that treatment of wastewater 
effluents with chlorine dioxide has potential to remove pharmaceuticals traces from wastewater 
treatment plant effluents. 
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Introduction  
One of the pressing problems in wastewater treatment plants (WWTPs) nowadays is the inability of 
conventional methods to quantitatively remove the large number of active pharmaceutical 
ingredients (APIs) due to their high resistance to biodegradation and/or limited biological activity 
especially in cold climates like Sweden. The heavy usage and hence the release of these complex 
mixture of untreated pharmaceuticals in the wastewater effluents may lead to significant surface 
and groundwater contamination compromising the health of the aquatic ecosystem and the 
environment [1, 2, 3].  
 
 
Where biological treatment is not sufficient, an improvement in WWTPs can be achieved by 
chemical oxidation as an additional treatment technology to remove potential pollutants that cannot 
be degraded biologically [4, 5, 6]. Among the chemical oxidants applied in water treatment and 
reported in literature, chlorine dioxide is one that merits further investigation on its potential to 
remove APIs in wastewater. Comparable to ozonation, the application of chlorine dioxide on 
drinking water, surface water and wastewater effluents treatment has shown promising results on 
pharmaceuticals removal. The non-steroidal anti-inflammatory drug diclofenac was among the 
pharmaceuticals completely degraded during drinking and surface water treatment at the lowest 
ClO2 dose applied [7]. In wastewater effluents, steroid estrogens were also removed fast at low 
doses of ClO2. At the same time, removal of estrogenic potency was also observed [8]. The 
removal of several antibiotics in water also demonstrated the reactivity of ClO2 [9, 10].   
 
 
In this study, the removal of a mixture of 53 different active pharmaceutical ingredients (APIs) in 
biologically treated wastewater was investigated in both low and high COD (chemical oxygen 
demand) effluents using different doses of chlorine dioxide. Effectiveness of the treatment was 
evaluated by monitoring the oxidant consumption and the amount of APIs removed. The aim of the 
study was to evaluate the potential for implementation of treatment of chlorine dioxide as a tertiary 
treatment step in municipal and hospital WWTPs. 
 
Materials and methods 
All chemicals except chloride dioxide were of analytical grade and purchased from Sigma-Aldrich.  
 
 
Preparation of chlorine dioxide stock solution: Chlorine dioxide was synthesized by mixing 400 ml 
demineralized water with equal volume of 25 ml each of 9% HCl and 7.5% NaClO2 and diluted to 
1000 ml with water. The solution was allowed to react by stirring in the dark for at least 1 hour. This 
resulted to approximately 1 g/l ClO2 solution. 
 
 
Oxidation experiment: Wastewater effluents were collected from two WWTPs in Sweden, one with 
extended nitrogen removal (Eff 1) and one without (Eff 2).  To characterize the wastewater, the pH 
and COD (Chemical oxygen demand measured spectrophotometrically by standardized Dr. Lange 
DR 2800 COD LCK 114 cuvette test) of the effluents were determined. Based on its respective 
COD value, the wastewater effluent was classified as low (Eff 1) and high (Eff 2) COD. The initial 
COD values of Eff 1 and Eff 2 were 35 and 55 mg/l, respectively. Effluent samples of 150 ml each 
were prepared in Schott Duran® bottles and spiked with mixed APIs to a final concentration of 
approx. 1 g/l. ClO2 was added to duplicate samples in the range from 0-20 mg/l. All samples were 
stored in the dark and allowed to react overnight (approx. 18h), thereafter, the pH and oxidant 
concentration of the samples were measured. Residual oxidants were removed by addition of 50 
mg/l sodium sulfite.  
 
 
Chlorine dioxide analysis: The concentration of ClO2 residual in all samples was quantified by 
reaction with DPD (N,N-diethyl-p-phenylenediamine) using the Allcon spectrophotometer (Alldos 
GmbH Germany) with a built-in calibration line for ClO2. The analysis of ClO2 with DPD was 
performed according to the photometer manufacturer (Alldos GmbH). 
 
 
APIs analysis: Samples of 100 ml treated effluent were filtered using a 0.45 m membrane filter 
(Millipore) then acidified to pH 3 using sulfuric acid. A 50 ng/l internal standard, a mixture of 13 13C 
labelled APIs, was added before solid-phase extraction (SPE). SPE columns (Oasis® HLB 3 cc/60 
mg, Waters) were conditioned serially with 5 ml each of methanol, ethyl acetate and acidified water 
(pH 3). Samples were extracted at a maximum flow rate of 2 ml/min. SPE columns were dried 
completely by drawing air through the columns for at least 30 min. The dried cartridges were eluted 
with 5 ml methanol followed by 2 ml ethyl acetate. The collected extracts were evaporated to 
dryness to change solvent to 30 % methanol with 0.1 % formic acid prior to analysis. A triple stage 
quadrupole MS/MS TSQ Quantum Ultra EMR (Thermo Fisher Scientific, San Jose, CA, USA) 
coupled with an Accela LC pump (Thermo Fisher Scientific, San Jose, CA, USA) and a PAL HTC 
autosampler (CTC Analytics AG, Zwingen, Switzerland) were used as analytical system. A 20 µL 
sample was loaded onto a Hypersil GOLD aQTM column (50 mm x 2.1 mm ID x 5 µm particles, 
Thermo Fisher Scientific, San Jose, CA, USA) preceded by a guard column. For elution of the 
analytes, a gradient flow with methanol and acetonitrile in water (all solvents buffered by 0.1% 
formic acid) was used. Both heated electrospray (HESI) and atmospheric pressure photoionization 
(APPI) in positive and negative ion modes were used for ionization of target compounds. Both first 
and third quadrupoles were operated at resolution 0.7 FMWH, and two or three selected reaction 
monitoring (SRM) transitions were monitored for each analyte. With SRM, the ion monitored in the 
first step is required to form a given fragment through a selected reaction in order to be positively 
identified. Samples were quantified using the SRM method and several calibration standards 
covering all concentration ranges were measured before, in the middle and at the end of sample 
sequences. The maximum difference between results at quantification and qualification mass 
transition was set to 30% as criterion for positive identification. The names of the APIs are 
mentioned in Figure 2. 
 
 
 
Results and discussion 
The initial pH of the effluents was 6.8 and 7.2 for Eff 1 and Eff 2, respectively and no further pH 
adjustments were made during the entire experiment. The pH in all samples did not change 
significantly after treatment even with the highest oxidant dose of 20 mg/l where pH remained 
slightly acidic (~pH 6.2).   
 
 
Figure 1 shows the concentration profile of ClO2 in the 2 effluents spiked with APIs. It can be seen 
that high COD effluent consumed more oxidant than low COD effluent which is evident when the 
dose was increased from 8 up to 20 mg/l ClO2. Table 1 summarizes the total number of APIs that 
can be removed by more than 90% at each ClO2 dose applied in both effluents. It shows that ClO2 
oxidation of wastewater effluent Eff 1 was able to remove 33 out of 53 APIs with 8 mg/l ClO2 and 
no further API removal was observed despite increasing the dose up to 20 mg/l. For Eff 2, most of 
the APIs were removed at 10 mg/l oxidant dose and increasing the dose two-fold only removed 1 
more API.  
 
 
The removal of the APIs in the 2 wastewater effluents varied from no significant removal with 20 
mg/l ClO2 to more than 90% removal with just 0.5 mg/l of the oxidant. As shown in Table 1 and 
Figure 2, only 4 APIs from the low COD effluent (Eff 1) namely promethazine, dipyridamole, 
clindamycine and buprenorphine were easily removed by more than 90% at the lowest dose of 0.5 
mg/l ClO2. With 1.25 mg/l ClO2, another 5 APIs, including hormones, (see Figure 2) were removed 
and by increasing further the oxidant dose, most of the APIs were already removed at 5 mg/l ClO2. 
For the high COD effluent (Eff 2), a dose of 0.5 mg/l ClO2 is not enough to allow any API removal. 
Removal of the same type of APIs as in Eff 1 was only observed when ClO2 dose was increased to 
1.25 mg/l and further increase in the number of APIs removed was evident after treatment with 8 
mg/l ClO2 as shown in Table 1 and Figure 3. In this case, the higher the COD content, the more 
oxidant the effluent needs to be able to remove the same compound. And, as can be expected, the 
high COD effluent has more recalcitrant APIs than the low COD effluent. In addition, the presence 
of other components in the wastewater aside from the APIs also consumes the oxidant resulting to 
a decrease in the removal of the target compounds [6]. 
 
 
As shown in the results for the 2 effluents, some of the APIs including diclofenac, sulfonamide 
antibiotic sulfamethoxazole and the estrogens, estriol, EE2 and estrone, were significantly 
removed at fairly low oxidant dose (1.25 - 3.75 mg/l) which was also observed in previous study 
done on surface and drinking water [7] and in wastewater effluents for a range of estrogens [8]. 
Similarly, the fluoroquinolone antibiotic ciprofloxacin also showed high reactivity to ClO2 when 
tested in both surface water and wastewater effluent [9]. No literature data on removal during 
treatment of wastewater with ClO2 has been found for the rest of the APIs that showed high 
reactivity to ClO2 (see Figures 2 and 3).  
 
 
The mechanism of API removal by ClO2 oxidation appears to be similar to ozonation as both are 
selective oxidants and capable of transforming organic contaminants based on reactivity of the 
structure and the presence of other constituents, mostly organics, in the wastewater. Certainly, 
these chemical oxidants react with electron-rich functional groups such as phenolic and amino 
groups and these can be found in the structures of most of the APIs removed in this study. For 
example in this study, the most reactive API promethazine contains an amine functional group and 
phenolic for the steroid estrogens which are believed to be highly reactive to chemical oxidation in 
a number of studies [6, 7, 12, 13, 14]. 
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Figure 2. Percentage removal of APIs in Eff 1 at different ClO2 doses. 
 
 
 
 
Figure 3. Percentage removal of APIs in Eff 2 at different ClO2 doses.  
 
 
 
 
Figure 1. Residual concentration of ClO2 in the 2 
effluents after treatment with different initial 
oxidant doses. 
  
No. of APIs removed  
by more than 90% 
ClO2 dose, mg/l Eff 1 Eff 2 
0.5 4 0 
1.25 9 4 
2.5 15 8 
3.75 24 12 
5 30 18 
8 33 29 
10 33 32 
20 33 33 
Table 1. Summary of the number of APIs 
that can be removed for each oxidant dose 
The remaining 20 APIs (data not shown) were oxidized by less than 90% in both wastewater 
effluents even at 20 mg/l treatment dose suggesting the low reactivity of these APIs to ClO2 
oxidation. Among the APIs not degraded significantly at 20 mg/l oxidant dose are carbamazepine, 
alprazolam, beclomethason, budesonide, bupropion, clonazepam, finasteride, flutamid, ibersartan, 
and telmisartan. Carbamazepine has been shown in previous investigations to be recalcitrant to 
ClO2 oxidation during drinking water [7] and wastewater treatment [6] except when treated in 
distilled water where around 50% removal of carbamazepine was reached [11].  Most of these 
APIs have not been investigated before and no data can show their reactivity towards oxidation by 
ClO2. As shown in this study, some APIs are fast oxidizing and are readily removed at low oxidant 
dose (see Figures 2 and 3) while others need more ClO2 or do not react at all [7].  This difference 
in API removal can be attributed to the reactivity of the respective functional group to ClO2 
oxidation.  
 
 
Compared to ozonation, ClO2 was able to oxidise fewer APIs effectively in the concentration range 
for ClO2 tested, but for a good part of the APIs that ClO2 react well with the treatment dose 
required for removal was comparable to the ozone dose required for the same removal. Since ClO2 
is slightly more expensive than ozone to produce then the running costs are considered, but it is 
less expensive to build an installation. The treatment perspective is mainly to use ClO2-treatment 
for small scale WWTP effluents or where treatment is required only for a limited time. 
 
 
Conclusions 
The removal of the APIs showed to be dependent on the type of wastewater, the one with 
extended nitrogen removal (low COD) has better API removal than the one without (high COD) for 
the same oxidant dose. In addition, the difference in API removal between the two wastewaters 
can be affected not only with its COD content but also the presence of other organic compounds in 
the wastewater that consumes ClO2. As an alternative to ozone, ClO2 can be applied during 
wastewater treatment in removing potentially toxic pharmaceuticals as long as the residual ClO2 is 
minimized and does not exceed the standard, which requires a minimal reaction time before 
contact with the receiving waters. The use of ClO2 oxidation for pharmaceutical wastewater 
treatment is especially beneficial in colder climates where biological treatment is not possible but 
taking into consideration the transformation products by carrying out toxicity evaluation of the 
treated effluent. 
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